Key stats
About Principal Healthcare Innovators ETF
Expense ratio
0.42%
Home page
Inception date
Aug 19, 2016
ISIN
US74255Y4098
BTEC seeks long-term capital growth by investing in small- and mid-cap companies in the Russell 3000 Healthcare Index. To build the portfolio, the fund utilizes a proprietary, quantitative model that emphasizes growth stocks and excludes the least liquid securities. The fund invests significantly in the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries, particularly in early-stage companies that are not yet consistently profitable. In constructing the model and managing the portfolio, the fund adviser uses insights from multiple sources, including internal research, industry reports, and third-party data. While the portfolio expects to rebalance at least annually, the fund adviser may make adjustments at its discretion. On July 15, 2022, the fund ceased tracking the NASDAQ U.S. Health Care Innovators Index and transitioned to an active management strategy.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region